This will be the 5th vaccine available in France.
The first deliveries of the American Novavax serum against Covid-19, which has just received the green light from the health authorities, "are expected the week of February 21" and not at the beginning of February as initially planned, the Ministry of Health said on Tuesday. .
France should receive “between 1.1 and 1.2 million doses” for the first delivery then “800,000 doses per week in March”, he specified.
On Friday, the High Authority for Health (HAS), responsible for guiding the government in its vaccine policy, gave the green light to the vaccine from the American laboratory.
On December 20, the European Medicines Agency had already given its approval.
Read alsoThese French people who are waiting for Novavax to get vaccinated
Health authorities hope that Novavax will convince reluctant people to get vaccinated with messenger RNA vaccines from Pfizer and Moderna, based on previously unseen technology.
That of Novavax indeed uses a more classic technology, similar to that of the whooping cough vaccine.
"The advantage of such technology is that it has proven itself for a long time," recently told the Parisian Stéphane Paul, immunologist at the Saint-Étienne University Hospital.
